Company page
Virax Biolabs Group Limited
Virax Biolabs Group Limited, trading under the ticker VRAX, is a public company based in the American market. The company has a market capitalization of approximately $3.67 million. Virax focuses on developing innovative solutions in the healthcare sector.
- Ticker
- VRAX:NASDAQ
- Asset type
- Stock
- Market cap
- $3.7M
- Sector
- Finance
- Industry
- Financial Conglomerates
- Exchange
- NASDAQ
- Currency
- USD